Source: Annual Congress 2009 - Clinical immunology of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Aydin, T. Cagatay, S. Sunmez, Z. Gulbaran, P. Cagatay, S. Kamal, Z. Kilicaslan (Istanbul, Turkey). Follow up results of patients receiving anti tumor necrosis antagonists and evaluation of risk of tuberculosis. Eur Respir J 2009; 34: Suppl. 53, 2567

Member's Comments

No comment yet.

Related content which might interest you: Follow up results for tuberculosis in patients who receive TNF antagonist treatment Source: Eur Respir J 2007; 30: Suppl. 51, 659s Year: 2007 Screening and monitoring of tuberculosis in patients on tumor necrosis factor antagonist therapy Source: Annual Congress 2011 - Clinical challenges in tuberculosis Year: 2011 The incidence of tuberculosis in patients taking anti TNF alpha therapy Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 Observation results of 484 patients that use TNF alfa inhibitor in respect of the risk of tuberculosis Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008 Screening for latent tuberculosis before tumour necrosis factor antagonist therapy Source: Eur Respir J 2015; 45: 1512-1513 Year: 2015 Screening for latent tuberculosis before tumour necrosis factor antagonist therapy Source: Eur Respir J 2015; 45: 1510-1512 Year: 2015 Characteristics of new tuberculosis cases diagnosed during treatment with TNF-alpha antagonists Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 The use of tumor necrosis factor alpha inhibitor pentoxifylline in the treatment of patients with I and II stages of pulmonary sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 542s Year: 2006 Isoniazid protection and risk of tuberculosis in patients who used anti tumor necrosis factor-alpha treatment Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease Year: 2007 Effectiveness of official recommendations on tuberculosis screening in patients on TNF antagonists Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 The risk of tuberculosis related to tumour necrosis factor antagonist therapies Source: Annual Congress 2011 - TBNET: tuberculosis research in Europe Year: 2011 Using an interferon-γ assay for the diagnosis of tuberculosis infection before using tumor necrosis factor-α blockers Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007 The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Source: Eur Respir J 2010; 36: 1185-1206 Year: 2010 Should isoniazid prophylaxis be prescribed to the patients under tumor necrosis factor-alpha antagonists independent of tuberculin skin test? Source: International Congress 2015 – Screening strategies in TB Year: 2015 Follow up of newly detected patients with destructive lung tuberculosis who were failed at the end of 8-month chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 648s Year: 2005 Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001 Evaluation of follow up and treatment results of new tuberculosis cases Source: Eur Respir J 2003; 22: Suppl. 45, 522s Year: 2003 Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis Source: Annual Congress 2012 - Tuberculosis and immunologic assays Year: 2012